Related Experiment Video
Updated: Jan 14, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Environmental lag effects and clinical characteristics of pediatric human parainfluenza virus type 3 infections
Dan Hong1, Minjuan Zhu2, Wanqing Qi3
1Department of Pediatrics, Xiangcheng Distric People's Hospital, No. 1060 Huayuan Road, Xiangcheng District, Suzhou, 215131, China.
Abstract:
Human parainfluenza virus type 3 (HPIV3) is a major cause of severe pediatric respiratory infections in infants, but its association with meteorological factors is not fully understood. This study compared clinical features of HPIV3 and respiratory syncytial virus (RSV) infections and used distributed lag nonlinear models (DLNMs) to identify environmental determinants of HPIV3 transmission. HPIV3 was most prevalent in infants, causing significantly less wheeze, tachypnea (both p < 0.001) and dyspnea (p = 0.044) than RSV. Seasonal prevalence showed a summer peak (46.4%) and a winter minimum (5.9%). High temperatures immediately increased the relative risk (RR) of HPIV3 (RR = 4.258, 95% CI 1.387-13.074), while low temperatures increased the RR after a four-month lag (RR = 3.958, 95% CI 1.858-8.430). PM10 exposure at 140 μg/m3 had the greatest immediate impact (lag 0, RR = 3.335, 95% CI 1.236-8.999). Delayed effects were observed for gaseous pollutants (SO2 and NO2) after five months (SO2: RR = 2.047, 95% CI 1.247-3.362; NO2: RR = 2.596, 95% CI 1.577-4.273). These findings indicate that HPIV3 shows distinct clinical features and differential environmental sensitivity, with acute responses to heat and particulates and delayed responses to cold and gaseous pollutants. These results support season-focused prevention strategies for vulnerable infants during high-risk periods.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pharmacokinetics in Pediatric Patients: Drug Excretion

